AbbVie closes $200M Nimble Therapeutics acquisition
AbbVie closes $200M Nimble Therapeutics acquisition
STARTS NOW! Rebel Edge π΄ββ οΈ1pm line up: U.S. crude oil prices are dropping due to weak demand from China and expected higher U.S. production after the election. WTI is notably lower, part of a wider commodity slump. Stocks $TSLA $COIN $ABBV $HOOD Sports Detroit's kicker makes 58β¦ https://t.co/mZXNAn84q8 https://t.co/HBCDrov0gz
Bristol Myers Squibbβs stock soars after rival AbbVie reports disappointing schizophrenia-drug trial
M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more
AbbVie to buy Aliada Therapeutics for $1.4B in cash
AbbVie wins FDA nod for infusion treatment for advanced Parkinsonβs disease
336BUSD
Lihat miliarder mana yang memiliki pelaburan ini
taip
Common Stock
Pertukaran
NYSE
Kod matawang
USD
Nama Mata Wang
US Dollar
Nama negara
USA
ISO negara
US
ADALAH DALAM
US00287Y1091
CUSIP
00287Y109
Sektor
Healthcare
industri
Drug Manufacturers - General
Akhir Tahun Fiskal
December
tarikh IPO
-
Dikemaskini Pada
-
Nisbah PE
79.48
Nisbah PEG
2.58
Nilai buku
3.41
Bahagian Dividen
0
Hasil Dividen
3.73%
Bahagian Pendapatan
2.39
Harga Sasaran Wall Street
204.90
Anggaran EPS Tahun Semasa
12.26
Anggaran EPS Tahun Depan
13.85
EPS Anggaran Suku Tahun Semasa
2.91
Anggaran EPS Suku Tahun Seterusnya
2.95
Suku Terkini
-
Hasil TTM
55,532,998,656
Keuntungan Kasar TTM
39,059,001,344
EBITDA
25,629,999,104
Margin keuntungan
9.22%
Pulangan Atas Aset TTM
7.72%
Pulangan Atas Ekuiti TTM
56.41%
Hasil Sesaham TTM
31.397
Pertumbuhan Hasil Qtly YOY
3.80%
Eps TTM yang dicairkan
2.39
Pertumbuhan Pendapatan Qtly YOY
-12.30%
PE mengekori
79.48
PE ke hadapan
15
Harga Jualan TTM
6.0445
Buku Harga MRQ
55.7036
Hasil Nilai Perusahaan
7
EBITDA Nilai Perusahaan
43
85.90
4.12%837.51
1.30%39.62
0.76%315.00
0.36%69.17
0.29%153.59
0.07%318.85
-7.09%139.54
-1.66%90.38
-0.36%104.75
-0.00%